PL1656358T3 - Trwały polimorf mesylanu bifeprunoksu - Google Patents
Trwały polimorf mesylanu bifeprunoksuInfo
- Publication number
- PL1656358T3 PL1656358T3 PL04766517T PL04766517T PL1656358T3 PL 1656358 T3 PL1656358 T3 PL 1656358T3 PL 04766517 T PL04766517 T PL 04766517T PL 04766517 T PL04766517 T PL 04766517T PL 1656358 T3 PL1656358 T3 PL 1656358T3
- Authority
- PL
- Poland
- Prior art keywords
- stable polymorph
- bifeprunox
- mesilate
- bifeprunox mesilate
- polymorph
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49570803P | 2003-08-18 | 2003-08-18 | |
EP03102573 | 2003-08-18 | ||
PCT/EP2004/051816 WO2005016898A2 (en) | 2003-08-18 | 2004-08-18 | Stable polymorph of bifeprunox mesilate |
EP04766517A EP1656358B1 (en) | 2003-08-18 | 2004-08-18 | Stable polymorph of bifeprunox mesilate |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1656358T3 true PL1656358T3 (pl) | 2011-07-29 |
Family
ID=34924088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04766517T PL1656358T3 (pl) | 2003-08-18 | 2004-08-18 | Trwały polimorf mesylanu bifeprunoksu |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1656358B1 (pl) |
JP (1) | JP2007502802A (pl) |
CN (1) | CN100422159C (pl) |
AR (1) | AR045362A1 (pl) |
AT (1) | ATE499348T1 (pl) |
AU (1) | AU2004265104B2 (pl) |
BR (1) | BRPI0413617A (pl) |
CA (1) | CA2536149C (pl) |
DE (1) | DE602004031534D1 (pl) |
DK (1) | DK1656358T3 (pl) |
EA (1) | EA008182B1 (pl) |
ES (1) | ES2361508T3 (pl) |
IS (1) | IS8279A (pl) |
ME (1) | MEP37108A (pl) |
MX (1) | MXPA06001881A (pl) |
MY (1) | MY139462A (pl) |
NO (1) | NO20061265L (pl) |
NZ (1) | NZ545415A (pl) |
PL (1) | PL1656358T3 (pl) |
PT (1) | PT1656358E (pl) |
RS (1) | RS20060113A (pl) |
SI (1) | SI1656358T1 (pl) |
TW (1) | TWI336695B (pl) |
UA (1) | UA85562C2 (pl) |
WO (1) | WO2005016898A2 (pl) |
ZA (1) | ZA200601399B (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7423040B2 (en) * | 2005-02-18 | 2008-09-09 | Irene Eijgendaal | Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same |
CA2654557A1 (en) * | 2006-06-16 | 2007-12-21 | Solvay Pharmaceuticals B.V. | Combination preparations comprising bifeprunox and l-dopa |
CA2661120A1 (en) * | 2006-08-31 | 2008-03-06 | Solvay Pharmaceuticals B.V. | Titration schedule for bifeprunox for treating schizophrenia and kits for use therein |
WO2011023796A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Healthcare Products B.V. | Bifeprunox for treating addiction |
US9556916B2 (en) | 2013-03-15 | 2017-01-31 | Whirlpool Corporation | High performance adjustable juicer with whole foods feed chute and clutch mechanism |
US9675101B2 (en) | 2013-03-15 | 2017-06-13 | Whirlpool Corporation | High performance adjustable juicer with whole foods feed chute |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI9708389B8 (pt) * | 1996-03-29 | 2015-12-08 | Duphar Int Res | compostos de piperazina e piperidina, composições farmacêuticas. |
IL127497A (en) * | 1997-12-18 | 2002-07-25 | Pfizer Prod Inc | Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders |
AU2003999A (en) * | 1997-12-19 | 1999-07-12 | Advanced Research And Technology Institute, Inc. | Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof |
AR034206A1 (es) * | 2001-02-16 | 2004-02-04 | Solvay Pharm Bv | Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos |
-
2004
- 2004-08-13 AR ARP040102906A patent/AR045362A1/es unknown
- 2004-08-16 TW TW093124532A patent/TWI336695B/zh not_active IP Right Cessation
- 2004-08-16 MY MYPI20043324A patent/MY139462A/en unknown
- 2004-08-18 RS YUP-2006/0113A patent/RS20060113A/sr unknown
- 2004-08-18 AU AU2004265104A patent/AU2004265104B2/en not_active Ceased
- 2004-08-18 ES ES04766517T patent/ES2361508T3/es active Active
- 2004-08-18 DK DK04766517.9T patent/DK1656358T3/da active
- 2004-08-18 MX MXPA06001881A patent/MXPA06001881A/es active IP Right Grant
- 2004-08-18 BR BRPI0413617-9A patent/BRPI0413617A/pt not_active IP Right Cessation
- 2004-08-18 PL PL04766517T patent/PL1656358T3/pl unknown
- 2004-08-18 JP JP2006523633A patent/JP2007502802A/ja active Pending
- 2004-08-18 DE DE602004031534T patent/DE602004031534D1/de active Active
- 2004-08-18 UA UAA200602994A patent/UA85562C2/ru unknown
- 2004-08-18 NZ NZ545415A patent/NZ545415A/en not_active IP Right Cessation
- 2004-08-18 CN CNB2004800235660A patent/CN100422159C/zh not_active Expired - Fee Related
- 2004-08-18 WO PCT/EP2004/051816 patent/WO2005016898A2/en active Application Filing
- 2004-08-18 EA EA200600442A patent/EA008182B1/ru not_active IP Right Cessation
- 2004-08-18 SI SI200431663T patent/SI1656358T1/sl unknown
- 2004-08-18 ME MEP-371/08A patent/MEP37108A/xx unknown
- 2004-08-18 CA CA2536149A patent/CA2536149C/en not_active Expired - Fee Related
- 2004-08-18 EP EP04766517A patent/EP1656358B1/en active Active
- 2004-08-18 AT AT04766517T patent/ATE499348T1/de active
- 2004-08-18 PT PT04766517T patent/PT1656358E/pt unknown
-
2006
- 2006-01-31 IS IS8279A patent/IS8279A/is unknown
- 2006-02-16 ZA ZA200601399A patent/ZA200601399B/en unknown
- 2006-03-20 NO NO20061265A patent/NO20061265L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2536149A1 (en) | 2005-02-24 |
DE602004031534D1 (de) | 2011-04-07 |
ES2361508T3 (es) | 2011-06-17 |
UA85562C2 (en) | 2009-02-10 |
CA2536149C (en) | 2011-03-22 |
RS20060113A (en) | 2008-09-29 |
PT1656358E (pt) | 2011-05-12 |
WO2005016898A3 (en) | 2005-04-07 |
NO20061265L (no) | 2006-05-09 |
AR045362A1 (es) | 2005-10-26 |
AU2004265104B2 (en) | 2009-06-04 |
ZA200601399B (en) | 2007-04-25 |
EA008182B1 (ru) | 2007-04-27 |
MEP37108A (en) | 2011-02-10 |
EP1656358B1 (en) | 2011-02-23 |
WO2005016898B1 (en) | 2005-05-19 |
MY139462A (en) | 2009-10-30 |
EA200600442A1 (ru) | 2006-08-25 |
DK1656358T3 (da) | 2011-05-30 |
JP2007502802A (ja) | 2007-02-15 |
ATE499348T1 (de) | 2011-03-15 |
TW200513462A (en) | 2005-04-16 |
IS8279A (is) | 2006-01-31 |
CN1835935A (zh) | 2006-09-20 |
TWI336695B (en) | 2011-02-01 |
EP1656358A2 (en) | 2006-05-17 |
NZ545415A (en) | 2009-11-27 |
CN100422159C (zh) | 2008-10-01 |
SI1656358T1 (sl) | 2011-06-30 |
BRPI0413617A (pt) | 2006-10-17 |
AU2004265104A1 (en) | 2005-02-24 |
MXPA06001881A (es) | 2006-05-17 |
WO2005016898A2 (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP1967A (en) | Thiazolidinone compounds as inhibitors of Hyak3 | |
ZA200605348B (en) | Solid forms of anti-EGFR-antibodies | |
HK1093483A1 (en) | Polymorphic form of n- | |
HK1173394A1 (zh) | 二酮哌嗪的合成 | |
SI1802579T1 (sl) | Derivati 3-arilaminopiridina | |
GB0321607D0 (en) | Manufacture of pharmaceutical compositions | |
IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
EP1745573A4 (en) | PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES | |
GB0305150D0 (en) | Use of therapeutic compounds | |
ZA200407609B (en) | Use of vitamin d compounds | |
EP1678157A4 (en) | Heterocyclic compounds and process for their preparation and use | |
TWI367753B (en) | Composition for normalization of infradian rhythm | |
IL175654A0 (en) | Cycloalkyl derivatives of 3-hydroxy -4-pyridinones | |
PL1656358T3 (pl) | Trwały polimorf mesylanu bifeprunoksu | |
EP1635836A4 (en) | PROMOTERS OF HETEROARYLIC COMPOUNDS | |
GB0207623D0 (en) | Crystal structure of g-quadruplex | |
GB0322963D0 (en) | Methods of controlling reducant addition | |
IL175528A0 (en) | Methods of preparing compounds useful as protease inhibitors | |
HK1091206A1 (en) | Stable polymorph of bifeprunox mesilate bifeprunox | |
GB0327742D0 (en) | Novel uses of known drugs | |
AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
PL1623977T3 (pl) | Związek pośredni stosowany do wytwarzania pioglitazonu | |
PL377902A1 (pl) | Nowe zastosowanie kompleksu fosfor-azot-metal | |
EP1486485A4 (en) | NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS | |
GB0317128D0 (en) | Use of antitumoral compounds |